The global factor Xa inhibitor market is projected to see significant development in the coming years. This movement can be attributed to a increasing prevalence of thromboembolic diseases worldwide, coupled with an elderly population. , In addition, advancements in technology have led to the development of more potent factor Xa inhibitors, boostin